More on BNTC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.60 |
|
|||
| Open | $10.44 | ||||
| 52 Wk High | $5.64 | ||||
| 52 Wk Low | $1.20 | ||||
| Day High | $11.61 | ||||
| Day Low | $10.25 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 251,968 | ||||
- Benitec BioPharma (BNTC) Reiterated at Market Outperform by Citizens After OPMD Data
- Benitec Biopharma to present BB-301 clinical data at muscular dystrophy conference
- Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
- Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
- Form 8-K Benitec Biopharma Inc. For: Feb 12
- Form 8-K Benitec Biopharma Inc. For: Feb 12
- Form 10-Q Benitec Biopharma Inc. For: Dec 31
- Form EFFECT Benitec Biopharma Inc.
- Form 424B3 Benitec Biopharma Inc.
- Benitec Biopharma (BNTC) files for 1.48M share offering by selling stockholders
Entities mentioned with BNTC
- FDA | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Show More...
